Experimental antibodies for Parkinson’s, Alzheimer’s may cause harmful inflammation
New computational models to understand colon cancer
29 March 2021New technique provides detailed map of lung pathology in COVID-19
29 March 2021Experimental antibodies for Parkinson’s, Alzheimer’s may cause harmful inflammation
A team led by scientists at Scripps Research has made a discovery suggesting that experimental antibody therapies for Parkinson’s and Alzheimer’s have an unintended adverse effect—brain inflammation—that may have to be countered if these treatments are to work as intended.
